Over-using chemotherapy in the adjuvant setting

详细信息    查看全文

• 作者：Giuseppe Curigliano^a ; ^{giuseppe.curigliano@ieo.it} ; Carmen Criscitiello^a ; Angela Esposito^a ; Giancarlo Pruneri^b ; ^c
• 关键词：Adjuvant chemotherapy ; Early breast cancer ; Overtreatment
• 刊名：The Breast
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：31
• 期：Complete
• 页码：303-308
• 全文大小：297 K
• 卷排序：31

文摘

The risk of overtreatment in breast cancer is a reality. An indeterminate overtreatment is associated with substantial risks of unexpected toxic effects. The “extended” adjuvant treatments in breast cancer subtypes may have higher risk of toxicity and limited benefit. It is essential to escalate treatment when necessary and to de-escalate when un-necessary.